SR ONE CAPITAL MANAGEMENT, LP Long-Term Concentrated

CIK: 0001910264 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 12, 2024

Total Value ($000): $238,157 (100.0% shares, 0.0% debt)

Holdings (5)

ACLX ARCELLX INC. 73.3%

Value ($000) $174,638 Shares 3,146,630 Est. Cost $16.72 Unrealized +169.8%

SPRY ARS PHARMACEUTICALS 9.2%

Value ($000) $21,991 Shares 4,012,903 Est. Cost $6.79 Unrealized -35.5%

DSGN DESIGN THERAPEUTICS INC 7.3%

Value ($000) $17,295 Shares 6,526,476 Est. Cost $16.67 Unrealized -86.3%

MLYS MINERALYS THERAPEUTICS 6.5%

Value ($000) $15,434 Shares 1,794,600 Est. Cost $16.83 Unrealized -53.4%

NKTX NKARTA INC. 3.7%

Value ($000) $8,800 Shares 1,333,333 Est. Cost $13.12 Unrealized -80.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC.	3,146,630	$174,638	73.3%	$16.72	+169.8%	COMMON STOCK	03940C100
SPRY	ARS PHARMACEUTICALS	4,012,903	$21,991	9.2%	$6.79	-35.5%	COM	82835W108
DSGN	DESIGN THERAPEUTICS INC	6,526,476	$17,295	7.3%	$16.67	-86.3%	COM	25056L103
MLYS	MINERALYS THERAPEUTICS	1,794,600	$15,434	6.5%	$16.83	-53.4%	COM	603170101
NKTX	NKARTA INC.	1,333,333	$8,800	3.7%	$13.12	-80.3%	COM	65487U108